Higher urinary heavy metal, arsenic, and phthalate concentrations in people with high blood pressure: US NHANES, 2009-2010

Blood Pressure

Volumn 23, Issue 6, 2014, Pages 363-369

  Shiue, Ivy ^a,b  

^a HERIOT WATT UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Blood pressure; Chemicals; Environmental health; Etiology; Hypertension; Molecular epidemiology; Risk factor

Indexed keywords

2 HYDROXYBIPHENYL; 4 HYDROXYBENZOIC ACID ESTER; 4,4' ISOPROPYLIDENEDIPHENOL; ANTIMONY; ARSENIC; ARSONIC ACID DERIVATIVE; COBALT; ENVIRONMENTAL CHEMICAL; HEAVY METAL; LEAD; MERCURY; MONO 2 ETHYL 5 CARBOXYPENTYL PHTHALATE; PHENOL DERIVATIVE; PHTHALIC ACID DERIVATIVE; TUNGSTEN; UNCLASSIFIED DRUG; PHTHALIC ACID; POLLUTANT;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLITE; RISK ASSESSMENT; UNITED STATES; URINE LEVEL; ADOLESCENT; COHORT ANALYSIS; MIDDLE AGED; NUTRITION; POLLUTANT; RISK FACTOR; STATISTICAL MODEL; URINE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARSENIC; COHORT STUDIES; ENVIRONMENTAL POLLUTANTS; HUMANS; HYPERTENSION; LOGISTIC MODELS; METALS, HEAVY; MIDDLE AGED; NUTRITION SURVEYS; PHTHALIC ACIDS; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84910619774     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2014.925228     Document Type: Article

References (42)

1. Gottlieb S. Nearly athird of US adults have high blood pressure. BMJ. 2004; 329: 531.
2. Revis NW, Zinsmeister AR, Bull R. Atherosclerosis and hypertension induction by lead and cadmium ions: An effect prevented by calcium ion. Proc Natl Acad Sci USA. 1981; 78: 6494-6498.
3. Carter DE, Aposhian HV, Gandolfi AJ. The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: Atoxicochemical review. Toxicol Appl Pharmacol. 2003; 193: 309-334.
4. Navas-Acien A, Silbergeld EK, Sharrett R, Calderon-Aranda E, Selvin E, Guallar E. Metals in urine and peripheral arterial disease. Environ Health Perspect. 2005; 113: 164-169.
5. Shiue I. Urine phthalate concentrations are higher in people with stroke: United States National Health and Nutrition Examination Surveys (NHANES), 2001-2004. Eur J Neurol. 2013; 20: 728-31.
6. Olsén L, Lind L, Lind PM. Associations between circulating levels of bisphenol Aand phthalate metabolites and coronary risk in the elderly. Ecotoxicol Environ Saf. 2012; 80: 179-183.
7. Heindel JJ. Endocrine disruptors and the obesity epidemic. Toxicol Sci. 2003; 76: 247-249.
8. Rogers JM, Ellis-Hutchings RG, Grey BE, Zucker RM, Norwood J Jr, Grace CE, et al. Elevated blood pressure in offspring of rats exposed to diverse chemicals during pregnancy. Toxicol Sci. 2013; doi: 10.1093/toxsci/kft248.
9. Newbold RR, Padilla-Banks E, Snyder RJ, Jefferson WN. Developmental exposure to estrogenic compounds and obesity. Birth Defects Res AClin Mol Teratol. 2005; 73: 478-480.
10. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention, http://www.cdc.gov/nchs/nhanes.htm [2012].
11. Silva MJ, Barr DB, Reidy JA, Malek NA, Hodge CC, Caudill SP, Brock JW, Needham LL, Calafat AM. Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ Health Perspect. 2004; 112: 331-338.
12. Mulligan KJ, Davidson TM, Caruso JA. Feasibility of the direct analysis of urine by inductively coupled argon plasma mass-spectrometry for biological monitoring of exposure to metals. J Anal At Spectrom. 1990; 5: 301-306.
13. Brock JW, Yoshimura Y, Barr JR, Maggio VL, Graiser SR, Nakazawa H, et al. Measurement of bisphenol Alevels in human urine. J Expo Anal Environ Epidemiol. 2001; 11: 323-328.
14. Calafat AM, Ye X, Wong LY, Bishop AM, Needham LL. Urinary concentrations of four parabens in the U.S. population: NHANES 2005-2006. Environ Health Perspect. 2010; 118: 679-685.
15. Hill Jr RH, Shealy DB, Head SL, Williams CC, Bailey SL, Gregg M, et al. Pesticide residues in urine of adults living in the United States: Reference range concentrations. Environ Res. 1995: 71: 99-108.
16. Hill RH Jr, Shealy DB, Head SL, Williams CC, Bailey SL, Gregg M, et al. Determination of pesticide metabolites in human urine using an isotope dilution technique and tandem mass spectrometry. J Anal Toxicol. 1995; 19: 323-329.
17. BMI Classification. World Health Organization.
18. La Kind JS, Goodman M, Naiman DQ. Use of NHANES data to link chemical exposures to chronic diseases: Acautionary tale. PLoS One. 2012; 7: e51086.
19. Expert Group on Vitamins and Minerals. Food Standard Agency; 2003.
20. Dalhamn T. The effect of cobalt on blood pressure, respiration and mortality, and the use of dimercaprol (BAL) as antidote. Acta Pharmacol Toxicol (Copenh). 1953; 9: 259-266.
21. Morvai V, Szakmáry É, Tátrai E, Ungváry G, Folly G. The effects of simultaneous alcohol and cobalt chloride administration on the cardiovascular system of rats. Acta Physiologica Hungarica. 1993; 81: 253-261.
22. Sandusky GE. Henk WG, Roberts ED. Histochemistry and ultrastructure of the heart in experimental cobalt cardiomyopathy in the dog. Toxicol Appl Pharmacol. 1981; 61: 89-98.
23. Heo Y, Parsons PJ, Lawrence DA. Lead differentially modifies cytokine production in vitro and in vivo. Toxicol Appl Pharmacol. 1996; 138: 149-157.
24. Vaziri ND, Ding Y, Ni Z. Compensatory up-regulation of nitric-oxide synthase isoforms in lead-induced hypertension; reversal by asuperoxide dismutase-mimetic drug. J Pharmacol Exp Ther. 2001; 298: 679-685.
25. Byrne JV, Hope JK, Hubbard N, Morris JH. The nature of thrombosis induced by platinum and tungsten coils in saccular aneurysms. AJNR Am J Neuroradiol. 1997; 18: 29-33.
26. ATSDR 2003. Toxicological profile for tungsten. Draft. Atlanta, GA: Agency for Toxic Substances and Disease Registry; 2003.
27. Peuster M, Fink C, von Schnakenburg C, Hausdorf G. Dissolution of tungsten coils does not produce systemic toxicity, but leads to elevated levels of tungsten in the serum and recanalization of the previously occluded vessel. Cardiol Young. 2002; 12: 229-235.
28. McCallum RI. The industrial toxicology of antimony. The Ernestine Henry lecture 1987. JR Coll Physicians Lond. 1989; 23: 28-32.
29. Schnorr TM, Steenland K, Thun MJ, Rinsky RA. Mortality in acohort of antimony smelter workers. Am J Ind Med. 1995; 27: 759-770.
30. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for antimony. US Public Health Service. Atlanta, GA: US Department of Health and Human Services; 1992.
31. US Department of Health and Human Services. Hazardous Substances Data Bank (HSDB, online database). Bethesda, MD: National Toxicology Information Program, National Library of Medicine; 1993.
32. Brotons JA, Olea-Serrano MF, Villalobos M, Pedraza V, Olea N. Xenoestrogens released from lacquer coatings in food cans. Environ Health Perspect. 1995; 103: 608-612.
33. Halden RU. Plastics and health risks. Annu Rev Public Health. 2010; 31: 179-194.
34. Heudorf U, Mersch-Sundermann V, Angerer J. Phthalates: Toxicology and exposure. Int J Hyg Environ Health. 2007; 210: 623-634.
35. Bisset KM, Dhopeshwarkar AS, Liao C, Nicholson RA. The Gprotein-coupled cannabinoid-1 (CB1) receptor of mammalian brain: Inhibition by phthalate esters in vitro. Neurochem Int. 2011; 59: 706-713.
36. Osman AM, van Dartel DA, Zwart E, Blokland M, Pennings JL, Piersma AH. Proteome profiling of mouse embryonic stem cells to define markers for cell differentiation and embryotoxicity. Reprod Toxicol. 2010; 30: 322-332.
37. Abir T, Rahman B, D'Este C, FA, Hilton H. The association between chronic arsenic exposure and hypertension: Ametaanalysis. J Toxicol. 2012; doi:10.1155/2012/198793.
38. Abhyankar L, Jones MR, Guallar E, Navas-Acien A. Arsenic exposure and hypertension: Asystematic review. Environ Health Perspect. 2012; 120: 494-500.
39. Jones MR, Tellez-Plaza M, Sharrett AR, Guallar E, Navas-Acien A. Urine arsenic and hypertension in US adults: The 2003-2008 National Health and Nutrition Examination Survey. Epidemiology. 2011; 22: 153-161.
40. Kumagai Y, Pi J. Molecular basis for arsenic-induced alternation in nitric oxide production and oxidative stress: Implication of endothelial dysfunction. Toxicol Appl Pharmacol. 2004; 198: 450-457. Ha MH, Lee DH, Son HK, Park SK, Jacobs DR Jr 41. Association between serum concentrations of persistent organic pollutants and prevalence of newly diagnosed hypertension: Results from the National Health and Nutrition Examination Survey 1999-2002. J Hum Hypertens. 2009; 23: 274-286.
41. Kopf PG, Walker MK. Overview of developmental heart defects by dioxins, PCBs, and pesticides. J Environ Sci Health CEnviron Carcinog Ecotoxicol Rev. 2009; 27: 276-285.
42. Smith EC, Padnos B, Cordon CJ. Peripheral versus central muscarinic effects on blood pressure, cardiac contractility, heart rate, and body temperature in the rat monitored by radiotelemetry. Pharmacol Toxicol. 2001; 89: 35-42.